ArticleHuman vaccines & immunotherapeutics2016
Disparities in collaborative patient-provider communication about human papillomavirus (HPV) vaccination.
Article in Human vaccines & immunotherapeutics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03604393 (Increasing Human Papillomavirus), which is not on this map. Cited by 30 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Increasing Human Papillomavirus (HPV) Immunization Rates: The Rural Adolescent Vaccine Enterprise (RAVE)
Who cites it
30 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- A narrative review of HPV vaccination interventions in rural U.S. communities.Preventive medicine · 2021Pooled it
- Provider communication about HPV vaccination: A systematic review.Human vaccines & immunotherapeutics · 2016Pooled it
- Boot Camp Translation using Community-Engaged messaging for adolescent Vaccination: A Cluster-Randomized trial.Vaccine · 2024Trial
- Review
- Identifying HPV vaccination research priorities for the US.Human vaccines & immunotherapeutics · 2025Article
- Evaluating intersectional variation of HPV-associated cancers in rural America.BMC public health · 2025Article
- Article
- Article
- Article
- The Evaluation of a Digital Health Intervention to Improve Human Papillomavirus Vaccine Recommendation Practices of Medical Students.Journal of cancer education : the official journal of the American Association for Cancer Education · 2023Article
- Patient-Provider Health Communication Strategies: Enhancing HPV Vaccine Uptake among Adolescents of Color.Healthcare (Basel, Switzerland) · 2023Article
- Cervical Cancer Prevention in Rural Areas.Annals of global health · 2023Review
- HPV Vaccine Communication Competency Scale for Medical Trainees: Interdisciplinary Development Study.JMIR formative research · 2022Article
- Socioeconomic impact of COVID-19 and willingness to be vaccinated in African American/Black and Hispanic/Latinx adults.Journal of the National Medical Association · 2022Article
- Perspectives on self-sampling for cancer screening among rural and urban women: Multilevel factors related to acceptability.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2022Article
- Supporting Patient-centered Communication on Adolescent Sexual and Reproductive Health-Perspectives to Build an Appointment Planning Tool.Journal of pediatric and adolescent gynecology · 2021Article
- Regular Healthcare Provider Status Does Not Moderate Racial/Ethnic Differences in Human Papillomavirus (HPV) and HPV Vaccine Knowledge.Vaccines · 2021Article
- Provider recommendation for HPV vaccination across Hispanic/Latinx subgroups in the United States.Human vaccines & immunotherapeutics · 2021Article
- Spatial Access to Vaccines for Children Providers in South Carolina: Implications for HPV Vaccination.Preventing chronic disease · 2020Article
- Effect of a multi-component intervention on providers' HPV vaccine communication.Human vaccines & immunotherapeutics · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundHealthcare providers may vary their communications with different patients, which could give rise to differences in vaccination coverage. We examined demographic disparities in parental report of collaborative provider communication and implications for human papillomavirus (HPV) vaccination.
methodsParticipants were 4,124 parents who completed the National Immunization Survey-Teen about daughters ages 13-17. We analyzed disparities in collaborative communication (mutual information exchange, deliberation, and decision) and whether they mediated the relationship between demographic characteristics and HPV vaccine initiation.
resultsHalf of parents (53%) in the survey reported collaborative communication. Poor, less educated, Spanish-speaking, Southern, and rural parents, and parents of non-privately insured and Hispanic adolescents, were least likely to report collaborative communication (all p<.05). These disparities in communication accounted for geographic variation in HPV vaccination, specifically, the higher rates of uptake in the Northeast versus the South (mediation z=2.31, p<.01) and in urban/suburban vs. rural areas (mediation z=2.87, p<.01). These disparities were also associated with vaccination among subgroups with relatively high coverage, minimizing what could have been even higher uptake among Hispanic compared to non-Hispanic white adolescents (mediation z=-3.04, p<.01) and non-privately versus privately insured adolescents (mediation z=-3.67, p<.001). Controlling for provider recommendation attenuated some of these associations (but all p<.10).
conclusionsCollaborative communication showed widespread disparities, being least common among underserved groups. Collaborative communication helped account for differences-and lack of differences-in HPV vaccination among some subgroups of adolescent girls. Leveraging patient-provider communication, especially for underserved demographic groups, could improve HPV vaccination coverage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.